CUAMC
INFI

China Universal Asset Management Company’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

China Universal Asset Management Company’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-836
Closed -$1K – 492
2022
Q3 		$1K Buy
+836
New +$902 ﹤0.01% 431

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

China Universal Asset Management Company's INFI Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 836 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in INFI in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 836 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Infinity Pharmaceuticals, Inc. position peaked at $1K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.